Cardiovascular Outcomes Report


2018 Outcomes & Quality Report in Cardiovascular Services

Innovations at a Glance

  • Served as co-principal investigators for a clinical trial determining MitraClip® percutaneous therapy significantly reduced hospitalizations and mortality for heart failure patients with mitral regurgitation

  • Applying 3D echocardiography, cardiac CT, and MRI for determining surgical and transcatheter intervention strategies to treat tricuspid regurgitation

  • Developed a novel minimally invasive surgical approach combining ECMO and the CentriMag ventricular assist device as a short-term circulatory support for cardiogenic shock

  • Performing the newly introduced Ozaki aortic valve repair in which the diseased aortic valve leaflets are removed to create a new aortic valve

    Ozaki aortic valve repair
  • Discovered a compound that dramatically reduces morbidity and mortality in patients with transthyretin amyloid cardiomyopathy

  • Described unique properties of adenosine that make it a specific electrophysiological probe for identifying underlying supraventricular arrhythmogenic mechanisms and confirming ablative success

  • Leading the first randomized trial between surgical and transcatheter mitral valve replacement — Apollo Trial

  • Developed a virtual myectomy technique using 3-dimensional reconstruction of gated cardiac CT to assist the intraoperative objective assessment of the myocardial resection

    3-dimensional reconstruction of gated cardiac CT
  • At the forefront of hybrid coronary revascularization for the treatment of multivessel disease

  • Developed novel 4D flow technique combining anatomical evaluation of the root with fluid-dynamic assessment of aortic flow to tailor surgical planning for aortic root replacement

    4D flow technique
  • Provide highly specialized expertise in pulmonary thromboendarterectomy to address chronic thromboembolic pulmonary hypertension